In summary, our data may identify lnc-LFAR1/Smad2/3 nexus as a novel regulator of TGFβ and Notch pathways in liver fibrosis, suggesting that lnc-LFAR1 may be a candidate anti-fibrotic target. Here, SMAD2 is linked to Hepatic fibrosis.